Gefitinib - Wikipedia - Iressa breast
- Views: 170 227
This is a phase II trial to assess whether IRESSA™ (gefitinib) has anti-tumour efficacy in patients with breast cancer. The trial proposes to enter. Gefitinib, under the trade name Iressa, marketed by AstraZeneca and Teva, is a drug employed to treat breast cancer. Additionally, gefitinib can also be.